Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
Title:
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
Author:
Bachert, Claus Han, Joseph K Desrosiers, Martin Hellings, Peter W Amin, Nikhil Lee, Stella E Mullol, Joaquim Greos, Leon S Bosso, John V Laidlaw, Tanya M Cervin, Anders U Maspero, Jorge F Hopkins, Claire Olze, Heidi Canonica, G Walter Paggiaro, Pierluigi Cho, Seong H Fokkens, Wytske J Fujieda, Shigeharu Zhang, Mei Lu, Xin Fan, Chunpeng Draikiwicz, Steven Kamat, Siddhesh A Khan, Asif Pirozzi, Gianluca Patel, Naimish Graham, Neil M H Ruddy, Marcella Staudinger, Heribert Weinreich, David Stahl, Neil Yancopoulos, George D Mannent, Leda P